Editorial: Neurotherapeutics of movement disorders.
作者信息
Factor Stewart A, Jankovic Joseph
机构信息
Department of Neurology, Emory University School of Medicine, 1841 Clifton Rd NE, Atlanta, GA, 30329, USA,
出版信息
Neurotherapeutics. 2014 Jan;11(1):3-5. doi: 10.1007/s13311-013-0241-2.
Abstract
摘要
相似文献
1
Editorial: Neurotherapeutics of movement disorders.社论：运动障碍的神经治疗学
Neurotherapeutics. 2014 Jan;11(1):3-5. doi: 10.1007/s13311-013-0241-2.
2
Advanced therapies for movement disorders in neurotherapeutics.神经治疗学中运动障碍的先进疗法。
Neurotherapeutics. 2008 Apr;5(2):163. doi: 10.1016/j.nurt.2008.02.005.
3
Introduction: The use of animal research in developing treatments for human motor disorders: brain-computer interfaces and the regeneration of damaged brain circuits.
ILAR J. 2007;48(4):313-6. doi: 10.1093/ilar.48.4.313.
4
A 21-Year Retrospective Study of the Toronto Western Hospital Deep Brain Stimulation Cohort.
Mov Disord. 2018 May;33(5):850-852. doi: 10.1002/mds.27359. Epub 2018 Mar 23.
5
Neurostimulation and functional brain imaging.
Neurol Res. 2000 Apr;22(3):318-25. doi: 10.1080/01616412.2000.11740677.
6
Closed-loop brain-machine-body interfaces for noninvasive rehabilitation of movement disorders.用于运动障碍无创康复的闭环脑机身体接口。
Ann Biomed Eng. 2014 Aug;42(8):1573-93. doi: 10.1007/s10439-014-1032-6. Epub 2014 May 15.
7
Deep brain stimulation for movement disorders.
Mov Disord. 2002;17 Suppl 3:S1-211.
8
Chronic deep brain stimulation for movement disorders.用于运动障碍的慢性深部脑刺激
Adv Tech Stand Neurosurg. 1999;25:61-136; discussion 136-8. doi: 10.1007/978-3-7091-6412-9_3.
9
Smart neuromodulation in movement disorders.运动障碍中的智能神经调节
Handb Clin Neurol. 2020;168:153-161. doi: 10.1016/B978-0-444-63934-9.00012-3.
10
Editorial: Update on movement disorders.
Curr Opin Neurol. 2024 Aug 1;37(4):392-393. doi: 10.1097/WCO.0000000000001281. Epub 2024 Jul 4.
本文引用的文献
1
Treatment of Huntington's disease.亨廷顿舞蹈症的治疗
Neurotherapeutics. 2014 Jan;11(1):153-60. doi: 10.1007/s13311-013-0244-z.
2
Treatment of restless legs syndrome.不宁腿综合征的治疗
Neurotherapeutics. 2014 Jan;11(1):177-87. doi: 10.1007/s13311-013-0247-9.
3
Treatment of functional (psychogenic) movement disorders.功能性（精神性）运动障碍的治疗。
Neurotherapeutics. 2014 Jan;11(1):201-7. doi: 10.1007/s13311-013-0246-x.
4
Treatment of movement disorder emergencies.运动障碍急症的治疗。
Neurotherapeutics. 2014 Jan;11(1):208-12. doi: 10.1007/s13311-013-0240-3.
5
Therapy for Parkinson's disease: what is in the pipeline?帕金森病的治疗：正在研发的有哪些？
Neurotherapeutics. 2014 Jan;11(1):24-33. doi: 10.1007/s13311-013-0242-1.
6
Treatment of Parkinson's disease: what's in the non-dopaminergic pipeline?帕金森病的治疗：非多巴胺能药物研发进展如何？
Neurotherapeutics. 2014 Jan;11(1):34-46. doi: 10.1007/s13311-013-0239-9.
7
Tardive dyskinesia: therapeutic options for an increasingly common disorder.迟发性运动障碍：针对一种日益常见疾病的治疗选择
Neurotherapeutics. 2014 Jan;11(1):166-76. doi: 10.1007/s13311-013-0222-5.
8
Treatment of cognitive, psychiatric, and affective disorders associated with Parkinson's disease.帕金森病相关认知、精神及情感障碍的治疗。
Neurotherapeutics. 2014 Jan;11(1):78-91. doi: 10.1007/s13311-013-0238-x.
9
Designing clinical trials for dystonia.肌张力障碍临床试验的设计
Neurotherapeutics. 2014 Jan;11(1):117-27. doi: 10.1007/s13311-013-0221-6.
10
Treatment of the sleep disorders associated with Parkinson's disease.帕金森病相关睡眠障碍的治疗。
Neurotherapeutics. 2014 Jan;11(1):68-77. doi: 10.1007/s13311-013-0236-z.
Zotero 插件